compound introduction
GPR120 Agonist 2 is a GPR120 agonist extracted from patent US 20110313003 A1, example 209. In Vitro GPR120 Agonist 2 is a GPR120 agonist which is useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:GPR120
